Depression, the autonomic nervous system, and coronary heart disease

Psychosomatic Medicine

Volumn 67, Issue SUPPL. 1, 2005, Pages

  Carney, Robert M ^a,c   Freedland, Kenneth E ^a   Veith, Richard C ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c Behavioral Medicine Center   (United States)

Author keywords

Autonomic nervous system; Coronary disease; Depression; Depressive disorder; Mortality; Myocardial infarction

Indexed keywords

CATECHOLAMINE;

AUTONOMIC DYSFUNCTION; CATECHOLAMINE BLOOD LEVEL; CORONARY RISK; DEPRESSION; DISEASE ASSOCIATION; HEART RATE VARIABILITY; HEART REPOLARIZATION; HUMAN; ISCHEMIC HEART DISEASE; MENTAL PATIENT; MORBIDITY; MORTALITY; PHYSICAL STRESS; PRESSORECEPTOR; PRIORITY JOURNAL; REVIEW; TACHYCARDIA;

EID: 14044261039     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.psy.0000162254.61556.d5     Document Type: Review

References (97)

1. Carney RM, Rich MW, Freedland KE, teVelde A, Saini J, Simeone C, Clark K. Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med 1988;50:627-33.
2. Barefoot JC, Helms MJ, Mark DB, Blumenthal JA, Califf RM, Haney TL, O'Connor CM, Siegler IC, Williams RB. Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiol 1996;78:613-7.
3. Frasure-Smith N, Lespèrance F, Talajic M. Depression and 18 month prognosis after myocardial infarction. Circulation 1995;91:999-1005.
4. Ahern DK, Gorkin L, Anderson JL, Tierney C, Ewart C, Capone RJ, Schron E, Kornfeld D, Herd JA, Richardson DW, Follick MJ. Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS). Am J Cardiol 1990;66:59-62.
5. Ladwig KH, Kieser M, Konig J, Breithardt G, Borggrefe M. Affective disorders and survival after acute myocardial infarction. Eur Heart J 1991;12:959-64.
6. Kaufmann MW, Fitzgibbons JP, Sussman EJ, Reed JF, Einfalt JM, Rodgers JI, Fricchione GL. Relation between myocardial infarction, depression, hostility, and death. Am Heart J 1999;138:549-54.
7. Denollet J, Sys SU, Brutsaert DL. Personality and mortality after myocardial infarction. Psychosom Med 1995;57:582-91.
8. Bush DE, Ziegelstein RC, Tayback M, Richter D, Stevens S, Zahalsky H, Fauerbach JA. Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am J Cardiol 2001;88:337-41.
9. Irvine J, Basinski A, Baker B, Jandciu S, Paquette M, Cairns J. Depression and risk of sudden cardiac death after acute myocardial infarction: testing for the confounding effects of fatigue. Psychosom Med 1999;61:729-37.
10. Carney RM, Blumenthal JA, Catellier D, Freedland KE, Berkman LF, Watkins LL, Czajkowski SM, Hayano J, Jaffe AS. Depression as a risk factor for mortality following acute myocardial infarction. Am J Cardiol 2003;92:1277-81.
11. Lespérance F, Frasure-Srnith N, Juneau M, Théroux P. Depression and 1-year prognosis in unstable angina. Arch Intern Med 2000;160:1354-60.
12. Connerney I, Shapiro P, McLaughlin JS, Sloan RP. In hospital depression after CABG surgery predicts 12-month outcome. Psychosom Med 2000; 62:106.
13. Blumenthal JA, Lett HS, Babyak MA, White W, Smith PK, Mark DB, Jones R, Mathew JP, Newman MF, for the NORG Investigators. Depression as a risk factor for mortality after coronary artery bypass surgery. Lancet 2003;362:604-9.
14. Burg MM, Benedetto CM, Rosenberg R, Soufer R. Depression prior to CABG predicts 6-month and 2-year morbidity and mortality. Psychosom Med 2001;63:103.
15. Mayou RA, Gill D, Thompson DR, Day A, Hicks N, Volmink J, Neil A. Depression and anxiety as predictors of outcome after myocardial infarction. Psychosom Med 2000;62:212-9.
16. Lane D, Carroll D, Ring C, Beevers G, Lip GYH. Mortality and quality of life 12 months after myocardial infraction: effects of depression and anxiety. Psychosom Med 2001;63:221-30.
17. Carney RM, Freedland KE. Depression, mortality and medical morbidity, in patients with coronary heart disease. Biol Psychiatry 2003;54:241-7.
18. Carney RM, Freedland KE, Rich MW, Jaffe AS. Depression as a risk factor for cardiac events in established coronary heart disease: a review of possible mechanisms. Ann Behav Med 1995;17:142-9.
19. Glassman AH, Shapiro PA. Depression and the course of coronary artery disease. Am J Psychiatry 1998;155:4-111.
20. Carney RM, Freedland KE, Miller GE, Jaffe AS. Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. J Psychosom Res 2002;53:897-902.
21. Cameron O. Depression increases post-MI mortality: how? [editorial] Psychosom Med 1996;58:111-2.
22. Kliks BR, Burgess MJ, Abildskov JA. Influence of sympathetic tone on ventricular fibrillation threshold during experimental coronary occlusion. Am J Cardiol 1975;36:45-9.
23. Podrid PJ, Fuchs T, Candinas R. Role of the sympathetic nervous system in the genesis of ventricular arrhythmia. Circulation 1990;82:103-10.
24. Schwartz PJ, Vanoli E. Cardiac arrhythmias elicited by interaction between acute myocardial ischemia and sympathetic hyperactivity: a new experimental model for the study of antiarrhythmic drugs. J Cardiovasc Pharmacol 1981;3:1251-9.
25. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ. Atherosclerosis: basic mechanisms. Circulation 1995;91:2488-96.
26. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340:115-26.
27. Markovitz JH, Matthews KA. Platelets and coronary heart disease: potential psychophysiologic mechanisms. Psychosom Med 1991;53:643-68.
28. Anfossi G, Tovati M. Role of catecholamines in platelet function: pathophysiological and clinical significance. Eur J Clin Invest 1996;32: 353-70.
29. Mussleman D. Depression, alterations in platelet function, and ischemic heart disease. Psychosom Med 2005;in press.
30. Kop W. The role of immune system parameters in the relationship between depression and coronary artery disease. Psychosom Med 2005;in press.
31. Barnes RF, Veith RC, Borson S, Verhey J, Raskind MA, Halter JB. High levels of plasma catecholamines in dexamethasone-resistant depressed patients. Am J Psychiatry 1983;140:1623-5.
32. Esler M, Turbott J, Schwarz R, Leonard P, Bobik A, Skews H, Jackman G. The peripheral kinetics of norepiniphrine in depressive illness. Arch Gen Psychiatry 1982;39:285-300.
33. Lake CR, Pickar D, Ziegler MG, Lipper S, Slater S, Murphy DL. High plasma NE levels in patients with major affective disorder. Am J Psychiatry 1982;139:1315-8.
34. Roy A, Pickar D, De Jong, J, Karoum F, Linnoila M. NE and its metabolites in cerebrospinal fluid, plasma, and urine. Arch Gen Psychiatry 1988;5:849-57.
35. Wyatt RJ, Portnoy B, Kupfer DJ, Snyder F, Engelman K. Resting plasma catecholamine concentrations in patients with depression and anxiety. Arch Gen Psychiatry 1971;24:65-70.
36. Siever L, Davis K. Overview: toward a dysregulation hypothesis of depression. Am J Psychiatry 1985;142:1017-31.
37. Veith RC, Lewis N, Linares OA, Barnes RF, Raskind MA, Villacres EC, Murburg MM, Ashleigh EA, Castillo S, Peskind ER, Pascualy M, Halter JB. Sympathetic nervous system activity in major depression. Arch Gen Psychiatry 1994;51:411-22.
38. Veith RC, Best JD, Halter JB. Dose-dependent suppression of norepinephrine appearance rate in plasma by clonidine in man. J Clin Endocrinol Metab 1984;59:151-5.
39. Esler M, Jennings G, Korner P, Willet I, Dudley F, Hasking G, Anderson W, Lambert G. Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension 1988;11:3-20.
40. Linares OA, Jacquez JA, Zech LA, Smith MJ, Sanfield JA, Morrow LA, Rosen SG, Halter JB. Norepinephrine metabolism in humans: kinetic analysis and model. J Clin Invest 1987;80:1332-41.
41. Dawson ME, Schell AM, Catania JJ. Autonomic correlates of depression and clinical improvement following electroconvulsive shock therapy. Psychophysiology 1977;14:569-78.
42. Lahmeyer HW, Bellier SN. Cardiac regulation and depression. Psychiatr Res 1987;21:1-6.
43. Kannel WB, Kannel C, Paffenbarger RS, Cupples LA. Heart rate and cardiovascular mortality: the Framingham study. Am Heart J 1987;113: 1489-94.
44. Dyer AR, Persky V, Stamler J, Paul O, Shekelle RB, Berkson DM, Lepper M, Schoenberger RA, Lindberg HA. Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol 1980;112:736-49.
45. Seccareccia F, Pannozzo F, Dima F, Minoprio A, Menditto A, LoNoce C, Giampaoli S. Heart rate as a predictor of mortality: the MATISS Project. Am J Public Health 2001;91:1258-63.
46. Palatini P, Julius S. Association of tachycardia with morbidity and mortality: pathophysiological considerations. J Hum Hypertens 1997;11: S19-27.
47. Palatini P. Heart rate as a risk factor for atherosclerosis and cardiovascular mortality. Drugs 1999;57:713-24.
48. Beere PA, Glagov S, Zarins CK. Retarding effect of lowered heart rate on coronary atherosclerosis. Science 1984;226:180-2.
49. Heidland UE, Strauer BE. Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption. Circulation 2001;104:1477-82.
50. Carney RM, Rich MW, teVelde A, Saini J, Clark K, Freedland KE. Heart rate, heart rate variability and depression in patients with coronary artery disease. J Psychosom Res 1988;32:159-64.
51. Carney RM, Freedland KE, Stein PK, Skala JA, Hoffman P, Jaffe AS. Change in heart rate and heart rate variability during treatment for depression in patients with coronary heart disease. Psychosom Med 2000;62:639-47.
52. Carney RM, Freedland KE, Veith RC, Cryer PE, Skala JA, Lynch T, Jaffe AS. Major depression, heart rate, and plasma norepinephrine in patients with coronary heart disease. Biol Psychiatry 1999;45:458-63.
53. Stein PE, Carney RM, Freedland KE, Skala JA, Kleiger RE, Rottman JN, Jaffe AS. Severe depression is associated with markedly reduced heart rate variability in patients with stable coronary heart disease. J Psychosom Res 2000;48:493-500.
54. Gotthardt U, Schweiger U, Fahrenberg J, Lauer CJ, Holsboer F, Heuser I. Cortisol, ACTH, and cardiovascular response to a cognitive challenge paradigm in aging and depression. Am J Physiol 1995;268:865-73.
55. Guinjoan SM, Bernabó JL, Cardinali DP. Cardiovascular tests of autonomic function and sympathetic skin responses in patients with major depression. J Neurol Neurosurg Psychiatry 1995;58:299-302.
56. Lehofer M, Moser M, Hoehn-Saric R, McLeod D, Liebmann P, Drnovsek B, Egner S, Hildebrandt G, Zapotoczky HG. Major depression and cardiac autonomic control. Biol Psychiatry 1997;42:914-9.
57. Light CK, Kothandapani RV, Allen MT. Enhanced cardiovascular and catecholamine responses in women with depressive symptoms. Int J Psychophysiology 1998;28:157-66.
58. vanDoornen LJP. The coronary risk personality: psychological and psychophysiological aspects. Psychother Psychsom 1980;34:204-15.
59. Task Force of the European Society of Cardiology and the North American Society for Pacing and Electrophysiology. Circulation 1996;93: 1043-65.
60. Kleiger RE, Miller JP, Bigger JT Jr, Moss AJ. Decreased heart rate variability and its association with mortality after myocardial infarction. Am J Cardiol 1987;113:256-62.
61. Bigger JT, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 1992;85:164-71.
62. Bigger JT, Fleiss JL, Rolnitzky LM, Steinman RC. Frequency domain measures of heart period variability to assess risk late after myocardial infarction. J Am Coll Cardiol 1993;21:729-36.
63. Vaishnav S, Stevenson R, Marchant B, Lagi K, Ranjadayalan K, Timmis AD. Relation between heart rate variability early after acute myocardial infarction and long-term mortality. Am J Cardiol 1994;73:653-7.
64. Rich MW, Saini JS, Kleiger RE, Carney RM, teVelde A, Freedland KE. Correlation of heart rate variability with clinical and angiographic variables and late mortality after coronary angiography. Am J Cardiol 1988; 62:714-7.
65. Dallack GW, Roose SP. Perspectives on the relationship between cardiovascular disease and affective disorder. J Clin Psychiatry 1990;51:4-9.
66. Imaoka K, Inoue H, Inoue Y, Hazama H, Tanaka T, Yamane N. R-R intervals of ECG in depression. Folia Psychiatr Neurol Jpn 1985;39: 485-8.
67. Rechlin T. Are affective disorders associated with alterations of heart rate variability? J Affect Disord 1994;32:271-5.
68. Yeragani VK, Pohl R, Balon R, Ramesh C, Glitz D, Jung I, Sherwood P. Heart rate variability in patients with major depression. Psychiatry Res 1992;37:35-46.
69. Carney RM, Saunders RD, Freedland KE, Stein P, Rich MW, Jaffe AS. Depression is associated with reduced heart rate variability in patients with coronary heart disease. Am J Cardiol 1995;76:562-4.
70. Krittayaphong R, Cascio WE, Light KC, Sheffield D, Golden RN, Finkel JB, Glekas G, Koch GG, Sheps DS. Heart rate variability in patients with coronary artery disease: differences in patients with higher and lower depression scores. Psychosom Med 1997;59:231-5.
71. Carney RM, Blumenthal JA, Stein PK, Watkins L, Catellier D, Berkman LF, Czajkowski SM, O'Connor C, Stone PH, Freedland KE. Depression, heart rate variability, and acute myocardial infarction. Circulation 2001; 104:2024-8.
72. Milner PG, Platia EV, Reid PR, Griffith LSC. Ambulatory electrocardiographic recordings at the time of fatal cardiac arrest. Am J Cardiol 1985;56:588-92.
73. Pratt CM, Francis MJ, Luck JC, Wyndham CR, Miller RR, Quinones MA. Analysis of ambulatory electrocardiograms in 15 patients during spontaneous ventricular fibrillation with special reference to preceding arrhythmic events. J Am Coll Cardiol 1983;2:789-97.
74. Carney RM, Freedland KE, Rich MW, Smith LJ, Jaffe AS. Ventricular tachycardia and psychiatric depression in patients with coronary artery disease. Am J Med 1993;95:23-8.
75. Schwartz PJ, Vanoli E, Stramba-Badiale M, DeFerrari GM, Billman GE, Foreman RD. Autonomic mechanisms and sudden death: new insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. Circulation 1988;78:969-79.
76. LaRovere MT, Pinna GD, Hohnloser SH. Baroreflex sensitivity and heart rate variability in identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation 2001;103: 2072-7.
77. Watkins LL, Grossman P. Association of depressive symptoms with reduced baroreflex cardiac control in coronary artery disease. Am Heart J 1999;137:453-7.
78. Watkins LL, Blumenthal JA, Carney RM. Association of anxiety with reduced baroreflex cardiac control in patient after acute MI. Am Heart J 2002;143:460-6.
79. Pitzalis MV, Iacoviello M, Todarello O, Fioretti A, Guida P, Massari F, Mastropasqua F, Russo GD, Rizzon P. Depression but not anxiety influences the autonomic control of heart rate after myocardial infarction. Am Heart J 2001;141:765-71.
80. Atiga WL, Calkins H, Lawrence JH, Tomaselli GF, Smith JM, Berger RD. Beat-to-beat repolarization lability identifies patients at risk for sudden cardiac death. J Cardiovasc Electrophysiol 1998;9:899-908.
81. Vrtovec B, Starc V, Starc R. Beat-to-beat QT interval variability in coronary patients. J Electrocardiol 2000;33:119-25.
82. Maison-Blanche P, Coumel P. Changes in repolarization dynamicity and the assessment of arrhythmic risk. Pacing Clin Electrophysiol 1997;20: 2614-24.
83. Bonnemeier H, Hartmann F, Wiegand UKH, Bode F, Katus HA, Richardt G. Course and prognostic implications of QT interval and QT interval variability after primary coronary angioplasty in acute myocardial infarction. J Am Coll Cardiol 2001;37:44-50.
84. Yeragani VK, Pohl R, Jampala VC, Balon R, Kay J, Igel G. Effect of posture and isoproterenol on beat-to-beat heart rate and QT variability. Neuropsychobiology 2000;41:113-23.
85. Carney RM, Freedland KE, Stein PK, Watkins L, Catellier D, Jaffe AS, Yeragani VK. Effects of depression on QT interval variability after myocardial infarction. Psychosom Med 2003;65:177-80.
86. Muller JE, Ludmer PL, Willich SN, Tofler GH, Aylmer G, Klangos I, Stone PH. Circadian variation in the frequency of sudden cardiac death. Circulation 1987;75:131-8.
87. Jakobsen J, Hauksson P, Vestergaard P. Heart rate variation in patients treated with antidepressants: an index of anticholinergic effects? Psychopharmacology 1984;84:544-8.
88. Rechlin T, Claus D, Weis M, Kaschka WP. Decreased heart rate variability parameters in amitriptyline treated depressed patients: biological and clinical significance. Eur Psychiatry 1995;10:189-94.
89. Yeragani VK, Pohl R, Balon R, Ramesh C, Glitz D, Weinberg P, Merlos B. Effect of imipramine treatment on heart rate variability measures. Neuropsychobiology 1992;26:27-32.
90. Shores MM, Pascualy M, Lewis NL, Flatness D, Veith RC. Short-term sertraline treatment suppresses sympathetic nervous system activity in healthy human subjects. Psychoneuroendocrinology 2001;26:433-9.
91. Balough S, Fitzpatrick DF, Hendricks SE, Paige SR. Increases in heart rate variability with successful treatment in patients with major depressive disorder. Psychopharmacol Bull 1993;29:201-6.
92. Kaykin Y, Dorian P, Baker B, Shapiro C, Sandor P, Mironov D, Irvine J, Newman, D. Autonomic correlates of antidepressant treatment using heart rate variability analysis. Can J Psychiatry 1998;43:183-6.
93. McFarlane A, Kamath M, Fallen EL, Malcom V, Cherian F, Norman G. Effect of sertraline on the recovery rate of cardiac autonomic function in depressed patients after acute myocardial infarction. Am Heart J 2001; 142:617-23.
94. Pohl R, Balon R, Jayaraman A, Doll RG, Yeragani V. Effect of fluoxetine, pemoline, and placebo on heart period and QT variability in normal humans. J Psychsom Res 2003;55:247-51.
95. Rechlin T, Weis M, Claus D. Heart rate variability in depressed patients and differential effects of paroxetine and amitriptyline on cardiovascular autonomic functions. Pharmacopsychiatry 1994;27:124-8.
96. Roose SP, Laghrissi-Thode F, Kennedy JS, Nelson JC, Bigger JT Jr., Pollock BG, Gaffney A, Narayan M, Finkel MS, McCafferty J, Gergel I. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA 1998;279:287-91.
97. Kjekshus JK. Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials. Am J Cardiol 1986;57:4-49.